Committee for Medicinal Products for Human Use (CHMP) issues positive recommendation for approval of Cholera vaccine (recombinant, live, oral) for prophylaxis against Vibrio cholera disease in adults and children

Cholera vaccine (Vaxchora) will be available as an effervescent powder and a powder for oral suspension to protect immunologically naïve people against moderate to severe diarrhoea induced by cholera bacteria.


European Medicines Agency